Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Ambu    AMBU B   DK0060946788

AMBU

(AMBU B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
03/25/2020 03/26/2020 03/27/2020 03/30/2020 03/31/2020 Date
164(c) 159.3(c) 159.3(c) 166.55(c) 165.2(c) Last
1 396 155 1 681 970 1 078 079 1 050 728 1 029 826 Volume
-2.35% -2.87% 0.00% +4.55% -0.81% Change
More quotes
Financials (DKK)
Sales 2020 3 573 M
EBIT 2020 476 M
Net income 2020 327 M
Debt 2020 1 500 M
Yield 2020 0,21%
Sales 2021 4 286 M
EBIT 2021 667 M
Net income 2021 494 M
Debt 2021 1 513 M
Yield 2021 0,33%
P/E ratio 2020 126x
P/E ratio 2021 83,3x
EV / Sales2020 11,8x
EV / Sales2021 9,82x
Capitalization 40 566 M
More Financials
Company
Ambu is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - emergency care and resuscitation devices (35.5%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion... 
More about the company
Surperformance© ratings of Ambu
Trading Rating : Investor Rating :
More Ratings
Latest news on AMBU
03/18AMBU A/S : Ambu's production exempt from Malaysian movement control order
AQ
03/17AMBU A/S : Malaysian government orders two-week movement control
AQ
02/12AMBU A/S : Capital increase in connection with exercise of warrants issued
AQ
02/04EUROPE : BP and Glencore drive best day in four months for European shares
RE
02/04AMBU : Interim report for Q1 2019/20 (no. 5)
PU
02/04AMBU A/S : Interim report for Q1 2019/20
AQ
01/22AMBU : King Systems Issues Recall of King Vision Video Laryngoscope Video Adapte..
PU
2019AMBU : 1st quarter report
CO
2019AMBU : Ex-dividend day for final dividend
FA
2019AMBU : Proxy Statments
CO
2019AMBU : Capital increase in connection with exercise of warrants (no. 3)
PU
2019AMBU A/S : Capital increase in connection with exercise of warrants issued
AQ
2019EUROPE : Trade woes, HK unrest knock European shares off 4-yr peak; Spain lags
RE
2019AMBU A/S : Changes within the board of directors of Ambu A/S
AQ
2019AMBU A/S : Annual report 2018/19 (Earnings release)
AQ
More news
News in other languages on AMBU
02/04AMBU : des trimestriels plus élevés que prévu
2019AMBU : Ex-dividend day for final dividend
2019AVIS D'ANALYSTES DU JOUR : Nike, Ulta Beauty, Dell, BMW, Crédit Agricole, Contin..
2019Les Bourses grimpent, l'euro et les taux baissent après Draghi
2019AMBU : chute lourdement après une nette révision de ses objectifs
More news
Chart AMBU
Duration : Period :
Ambu Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMBU
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 145,57  DKK
Last Close Price 165,20  DKK
Spread / Highest target 18,6%
Spread / Average Target -11,9%
Spread / Lowest Target -46,7%
EPS Revisions
Managers
NameTitle
Juan-José Gonzalez Chief Executive Officer
Lars Søren Rasmussen Chairman
Henrik Ankjær Executive Vice President-Global Operations
Michael Højgaard Chief Financial Officer & Executive Vice President
Mikael Worning Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
AMBU42.61%6 042
MEDTRONIC PLC-18.86%123 362
BAXTER INTERNATIONAL INC.-1.71%41 687
HOYA CORPORATION-1.04%33 591
TERUMO CORPORATION2.80%25 770
DEXCOM, INC.27.09%25 463